GENETIC SIGNATURES LIMITED

3.03%

34.0¢

Market Cap $77.22M

Technology Scientific & Technical Instruments

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx)... Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company's principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit, and others. More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Latest Threads

Tag

Subject

GSS

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

23/07/25

824

23/07/25

Last post thongo

824

GSS

Ann: Strategic Partnership with Tecan and Repado

22/07/25

634

22/07/25

Last post suhm

634

GSS

Ann: 1H FY25 Market Update

21/07/25

6.3K

21/07/25

Last post Champee

6.3K

GSS

Ann: Notification of cessation of securities - GSS

30/06/25

257

30/06/25

Last post

ASX News

257

GSS

Ann: FDA Clearance For Gastrointestinal Parasite Detection Kit

24/06/25

14K

24/06/25

Last post cambam

14K

GSS

Ann: 1H FY25 Results and Investor Webinar Notification

21/06/25

711

21/06/25

Last post suhm

711

GSS

Ann: Change in substantial holding

16/06/25

379

16/06/25

Last post

ASX News

379

GSS

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

16/06/25

6.1K

16/06/25

Last post Vetpal

6.1K

See All Discussions

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
22 Jul 08:43	Share

Strategic Partnership with Tecan and Repado
22 Jul 08:38	Share

Notification of cessation of securities - GSS
30 Jun 11:08	Share

Change in substantial holding
16 Jun 16:53	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 10:12	Share

Notification of cessation of securities - GSS
28 Feb 15:10	Share

1H FY25 Market Update
26 Feb 10:14	Share

Positive Momentum For The First Half Result
26 Feb 10:13	Share

Half Yearly Report and Accounts
26 Feb 10:12	Share

1H FY25 Results and Investor Webinar Notification
25 Feb 10:12	Share

Appointment of Joint Company Secretary
03 Feb 11:41	Share

Appendix 3Y - Late Lodgement Notice
03 Feb 08:27	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jan 09:24	Share

Change of Director's Interest Notice
17 Dec 08:31	Share

Application for quotation of securities - GSS
17 Dec 08:21	Share

Notification regarding unquoted securities - GSS
09 Dec 08:35	Share

Notification of cessation of securities - GSS
27 Nov 16:33	Share

Application for quotation of securities - GSS
25 Nov 16:49	Share

$5m R&D Tax Incentive Received
22 Nov 10:16	Share

Final Director's Interest Notice
20 Nov 17:27	Share

AGM Results of Meeting
20 Nov 14:24	Share

2024 AGM Chairman's Address and CEO Presentation
20 Nov 08:20	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Oct 08:41	Share

Notice of Annual General Meeting/Proxy Form
18 Oct 16:02	Share

Notification regarding unquoted securities - GSS
14 Oct 08:29	Share

Initial Director's Interest Notice - Jenny Harry
01 Oct 08:44	Share

Initial Director's Interest Notice - Anne Lockwood
01 Oct 08:40	Share

Final Director's Interest Notice
20 Sep 08:40	Share

Board Composition Update
20 Sep 08:25	Share

Becoming a substantial holder
18 Sep 16:06	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 34.0¢		Change 0.010(3.03%)		Mkt cap ! $77.22M

Open	High	Low	Value	Volume
34.0¢	34.0¢	32.5¢	$39.38K	118.0K

Buyers (Bids)

No.	Vol.	Price($)
2	2791	32.5¢

Sellers (Offers)

Price($)	Vol.	No.
34.0¢	8663	1

View Market Depth

No.	Vol.	Price($)
2	2791	0.325
2	33000	0.320
3	33177	0.315
2	56000	0.310
2	51374	0.300

Price($)	Vol.	No.
0.340	8663	1
0.355	158869	3
0.380	1500	1
0.395	2534	1
0.400	8000	1

Last trade - 15.03pm 01/08/2025 (20 minute delay)

GSS (ASX) Chart

GENETIC SIGNATURES LIMITED

Latest Threads

Redcastle Resources Delivers Positive Scoping Study for Queen Alexandra

Timeline

Featured News

Latest Articles

Genetic Signatures wins TGA greenlight for flu test device – just before winter

Genetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reported a greenlight from the TGA.

Buyers (Bids)

Sellers (Offers)

Codeifai looks to ride AI wave as Quantum Computing becomes a necessity

Prospect Resources: Replicating the success of Arcadia with ~1b tonne copper ore target

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Featured News